Aadi Bioscience (AADI) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Aadi Bioscience Revenue Highlights


Latest Revenue (Y)

$24.35M

Latest Revenue (Q)

$6.18M

Main Segment (Y)

Product

Aadi Bioscience Revenue by Period


Aadi Bioscience Revenue by Year

DateRevenueChange
2023-12-31$24.35M60.06%
2022-12-31$15.22M1421.60%
2021-12-31$1.00M-92.86%
2020-12-31$14.00M1769.16%
2019-12-31$749.00K-96.28%
2018-12-31$20.16M100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31--

Aadi Bioscience generated $24.35M in revenue during NA 2023, up 60.06% compared to the previous quarter, and up 120.82% compared to the same period a year ago.

Aadi Bioscience Revenue by Quarter

DateRevenueChange
2024-06-30$6.18M15.43%
2024-03-31$5.35M-15.38%
2023-12-31$6.33M6.16%
2023-09-30$5.96M-3.92%
2023-06-30$6.20M5.71%
2023-03-31$5.87M12.24%
2022-12-31$5.23M23.13%
2022-09-30$4.25M23.51%
2022-06-30$3.44M48.98%
2022-03-31$2.31M130.70%
2021-12-31$1.00M100.00%
2021-09-30-100.00%
2021-06-30--100.00%
2021-03-31$120.00K-99.14%
2020-12-31$14.00M5960.61%
2020-09-30$231.00K158.43%
2020-06-30$89.39K-19.15%
2020-03-31$110.56K100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--100.00%
2018-12-31$2.14K-99.99%
2018-09-30$18.82M1311.65%
2018-06-30$1.33M100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30--

Aadi Bioscience generated $6.18M in revenue during Q2 2024, up 15.43% compared to the previous quarter, and up 105.32% compared to the same period a year ago.

Aadi Bioscience Revenue Breakdown


Aadi Bioscience Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 19Dec 18
Product$24.35M$15.22M---
Grant--$120.00K--
License--$1.00M$20.00M$20.00M

Aadi Bioscience's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Sep 21Sep 18Jun 18
Product$5.35M$6.33M$5.96M$6.20M$5.87M$5.23M$4.25M$3.44M$2.31M---
Grant--------$120.00K---
License----------$18.70M$1.30M

Aadi Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (100.00%).

Aadi Bioscience Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
RAREUltragenyx Pharmaceutical$434.25M$147.03M
ARVNArvinas$78.50M$102.40M
AADIAadi Bioscience$24.35M$6.18M
ADAGAdagene$18.11M$833.34K
ANABAnaptysBio$17.16M$10.97M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
CRNXCrinetics Pharmaceuticals$4.01M$640.00K
ANEBAnebulo Pharmaceuticals--
DSGNDesign Therapeutics--
RZLTRezolute--
ANTXAN2 Therapeutics--
GRCLGracell Bio--
AVTEAerovate Therapeutics--
KURAKura Oncology--
ERASErasca--
ACRVAcrivon Therapeutics--
MLYSMineralys Therapeutics--
GLUEMonte Rosa Therapeutics-$4.70M

AADI Revenue FAQ


Aadi Bioscience's yearly revenue for 2023 was $24.35M, representing an increase of 60.06% compared to 2022. The company's yearly revenue for 2022 was $15.22M, representing an increase of 1421.60% compared to 2021. AADI's yearly revenue for 2021 was $1M, representing a decrease of -92.86% compared to 2020.

Aadi Bioscience's quarterly revenue for Q2 2024 was $6.18M, a 15.43% increase from the previous quarter (Q1 2024), and a -0.37% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $5.35M, a -15.38% decrease from the previous quarter (Q4 2023), and a -8.76% decrease year-over-year (Q1 2023). AADI's quarterly revenue for Q4 2023 was $6.33M, a 6.16% increase from the previous quarter (Q3 2023), and a 21.03% increase year-over-year (Q4 2022).

Aadi Bioscience's revenue growth rate for the last 3 years (2021-2023) was 2335.40%, and for the last 5 years (2019-2023) was 3151.54%.

Aadi Bioscience's revenue streams in c 23 are Product

For the fiscal year ending Dec 23, the largest source of revenue of Aadi Bioscience was Product. This segment made a revenue of $24.35M, representing 100.00% of the company's total revenue.